Balloon Dilatation for Native Coarctation of the Aorta in Neonates and Infants: Evaluating Early Outcomes and Age-Related Differences

Abstract

Coarctation of the aorta (CoA) represents a significant proportion of congenital heart disease and remains a major cause of morbidity in early life. Timely intervention is essential, particularly in neonates where ductal closure may precipitate rapid clinical deterioration. Although surgical repair has traditionally been considered the standard of care, catheter-based interventions, including balloon dilatation, have gained increasing acceptance in selected patient populations. The study by Javed et al. provides important data regarding the immediate and short-term outcomes of balloon dilatation in neonates and infants, with a particular focus on age-related differences [1]. The authors report a significant reduction in transcoarctation gradient following balloon dilatation, confirming the effectiveness of the procedure in relieving obstruction. This finding is consistent with prior studies demonstrating that balloon angioplasty can achieve rapid hemodynamic improvement, particularly in critically ill patients requiring urgent intervention [2,3]. The observed reduction in median gradient and the acceptable rate of immediate procedural success support the role of balloon dilatation as a therapeutic option in early life. A key strength of this study is the comparison between neonates and infants. The results demonstrate that infants have significantly higher procedural success rates and better short-term outcomes compared to neonates. Lower post-procedure gradients and greater gradient reduction in infants suggest that anatomical and physiological factors associated with age play an important role in procedural efficacy. Neonates often present with smaller vessel size, increased vascular fragility, and associated arch hypoplasia, all of which may limit optimal balloon expansion and contribute to suboptimal results [4,5]. The study further highlights a clinically important issue: the risk of recoarctation. The overall recoarctation rate at six months was 23.47%, with a substantially higher incidence in neonates compared to infants. This observation is consistent with previously published data indicating that younger age at intervention is associated with increased risk of restenosis [6,7]. The identification of age as an independent predictor of recoarctation through multivariable analysis strengthens the validity of this finding and emphasizes the importance of age-specific treatment strategies. From a clinical perspective, these findings suggest that while balloon dilatation provides effective short-term relief, its durability in neonates remains limited. In this subgroup, the procedure may be more appropriately considered as a palliative or bridging intervention rather than definitive therapy. In contrast, infants appear to derive greater benefit, with improved procedural success and lower rates of recurrence, supporting the use of balloon dilatation as a more definitive option in selected cases. The safety profile reported in this study is reassuring. The low rate of major complications indicates that balloon dilatation can be performed safely in experienced centers. This is particularly relevant in settings where surgical resources may be limited or where critically ill patients may not be optimal candidates for immediate surgery [3,8]. In addition to hemodynamic outcomes, the study provides data on clinical improvement, including resolution of heart failure symptoms, improved feeding, and stabilization of vital parameters. These outcomes are clinically meaningful and reinforce the benefit of timely intervention. The greater degree of clinical improvement observed in infants further supports the influence of age on both physiological recovery and overall outcomes [9]. Despite its strengths, several limitations should be considered. The study is based on a single-center experience, which may limit generalizability. The ambispective design introduces potential limitations related to retrospective data collection. Furthermore, the follow-up period of six months is relatively short and does not allow assessment of long-term outcomes such as late recoarctation, aneurysm formation, or persistent hypertension. Future studies with longer follow-up and multicenter collaboration would be valuable. Another consideration is the role of anatomical factors such as arch hypoplasia and lesion morphology. Although arch hypoplasia was not identified as an independent predictor of recoarctation in this study, this may be related to sample size limitations. More detailed anatomical assessment may help refine risk stratification [10]. Balloon dilatation is an effective and relatively safe intervention for native CoA in early life, particularly in infants. However, the higher rate of recoarctation in neonates underscores the need for careful patient selection and close follow-up. Further research is required to evaluate long-term outcomes and optimize age-specific treatment strategies. References Javed S, Shaikh AS, Korejo HB, Kumari V, Ahsan AK, Rafique N. Immediate and Short-Term Outcomes of Balloon Dilatation for Native Coarctation of the Aorta in Neonates and Infants at a Tertiary Care Center. Pak Heart J. 2026;59(02):461-9. DOI: 10.47144/phj.v59i2.3523 Rao PS, Galal O, Smith PA, Wilson AD. Five- to nine-year follow-up results of balloon angioplasty of native aortic coarctation in infants and children. J Am Coll Cardiol. 1996;27(2):462-70. DOI: 10.1016/0735-1097(95)00479-3 Arora HS, Vidya P, Ghosh AK, Mishra SC, Shouche S, Sethi BS, et al. Midterm safety and outcome of balloon angioplasty of native aortic coarctation in neonates and young infants. Ann Pediatr Cardiol. 2022;15(2):121-7. DOI: 10.4103/apc.apc_197_21 Chetan D, Mertens LL. Challenges in diagnosis and management of coarctation of the aorta. Curr Opin Cardiol. 2022;37(1):115-22. DOI: 10.1097/HCO.0000000000000934 Stephens EH, Feins EN, Karamlou T, Anderson BR, Alsoufi B, Bleiweis MS, et al. Management of neonates and infants with coarctation of the aorta. Ann Thorac Surg. 2024;118(2):527-44. DOI: 10.1016/j.athoracsur.2024.04.012 Liang CD, Su WJ, Chung HT, Hwang MS, Huang CF, Lin YJ, Chien SJ, Lin IC, Ko SF. Balloon angioplasty for native coarctation of the aorta in neonates and infants with congestive heart failure. Pediatr Neonatol. 2009;50(4):152-7. DOI: 10.1016/S1875-9572(09)60054-1 Sandoval JP, Kang SL, Lee KJ, Benson L, Asoh K, Chaturvedi RR. Balloon Angioplasty for Native Aortic Coarctation in 3- to 12-Month-Old Infants. Circ Cardiovasc Interv. 2020;13(11):e008938. DOI: 10.1161/CIRCINTERVENTIONS.120.008938 Hysko K, Bertram H, Bobylev D, Horke A, Hansmann G. Advances in the treatment of neonatal coarctation of the aorta. Pediatrics. 2025;155(3):e2024067434. DOI: 10.1542/peds.2024-067434 Amoozgar H, Bahmanpour N, Farhadi P, Edraki MR, Borzouee M, Ajami G, et al. Balloon angioplasty for native coarctation in children: immediate outcome and follow-up. Int Cardiovasc Res J. 2015;9(1):e10542. https://brieflands.com/journals/ircrj/articles/10542 Vasile CM, Laforest G, Bulescu C, Jalal Z, Thambo JB, Iriart X. From Crafoord's End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation Management Strategies and Reinterventions. J Clin Med. 2023;12(23):7350. DOI: 10.20944/preprints202310.1295.v1